Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates

Infection and Immunity

Volumn 64, Issue 7, 1996, Pages 2824-2828

  Brett, Paul J ^a   Woods, Donald E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FLAGELLIN; GLYCOCONJUGATE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN STRUCTURE; STRAIN DIFFERENCE;

EID: 0029991543     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.7.2824-2828.1996     Document Type: Article

References (27)

1. Brett, P. J., C. W. Mah, and D. E. Woods. 1994. Isolation and characterization of Pseuclomonas pseudomallei flagellin proteins. Infect. Immun. 62 1914-1919.
2. Bryan, L. E., S. Wong, D. E. Woods, D. A. B. Dance, and W. Chaowagul. 1994. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can. J. Infect. Dis. 5170-178.
3. Chaowagul, W., N. J. While, D. A. B. Dance, Y. Wattanagoon, P. Naignwit, T. M. E. Davis, S. Looareesuwan, and N. Pitakwhatchara. 1989. Melioidosis a major cause of community-acquired septicemia in northeastern Thailand. J. Infect. Dis. 159890-899.
4. Cryz, S. J., Jr., J. C. Sadoff, E. Furer, and R. Germanier. 1986. Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine safety and immunogenicity in humans. J. Infect. Dis. 154682-688.
5. Dar, L., R. Thakur, and V. S. Dar. 1994. India is it plague? Lancet 3441359.
6. Dean, P. G. D., W. S. Johnson, and F. A. Middle. 1987. Affinity chromatography a practical approach, p. 46-47. IRL Press, Oxford.
7. Dintzis, R. Z., M. H. Middleton, and H. M. Dintzis. 1983. Studies on the immunogenicity and tolerance of T-independent antigens. J. Immunol. 131 2196-2203.
8. Dintzis, R. Z., M. H. Middleton, and H. M. Dintzis. 1985. Inhibition of anti-DNP antibody formation by high doses of DNP-polysaccharide molecules effect of hapten density and valence. J. Immunol. 143423-427.
9. Drewry, T. D., G. W. Gray, and S. G. Wilkinson. 1971. Release of ethanolamine pyrophosphate during mild acid hydrolysis of the lipopolysaccharide of Pseudomonas aeruginosa. Eur. J. Biochem. 21400-403.
10. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28350-356.
11. Herzenberg, L. A., T. Tokuhisa, and L. A. Herzenberg. 1980. Carrier priming leads to hapten-spccific suppression. Nature (London) 285665-666.
12. Jennings, H. 1992. Further approaches for optimizing polysaccharide-protein conjugate vaccines for prevention of invasive bacterial disease. J. Infect. Dis. 165S156-S159.
13. Jennings, H., and C. Lugowski. 1981. Immunochemistry of groups A. B, and C meningococcal polysaccharide-tetanus loxoid conjugates. J. Immunol. 127 1011-1018.
14. Johnson, K. G., and M. B. Perry. 1975. Improved techniques for the preparation of bacterial lipopolysaccharides. Can. J. Microbiol. 2229-34.
15. Knirel, Y. A., N. A. Paramonov, A. S. Shashkov, N. K. Kochetkov, R. G. Vanillin, S. M. Farber, and V. I. Efermenko. 1992. Structure of the polysaccharide chains of Pseudomonas pseudomallei lipopolysaccharides. Carbohydr. Res. 233185-193.
16. Leelarasamee, A., and S. Bovornkitti. 1989. Melioidosis review and update. Rev. Infect. Dis. 11413-425.
17. Peelers, C. C. A. M., A.-M. Tenbergen-Meekes, J. T. Poolman, M. Beurret, B. J. M. Zegers, and G. T. Rijkers. 1991. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect. Immun. 593504-3510.
18. Perry, M. B., L. L. MacLean, T. Schollaardt, L. E. Bryan, and M. Ho. 1995. Structural characterization of the lipopolysaccharide O-antigens of Burkholderia pseudomallei. Infect. Immun. 633348-3352.
19. Reed, L. J., and H. Muench. 1937. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27493-497.
20. Sanford, J. P. 1985. Pseudomonas species (including melioidosis and glanders), p. 1250-1254. In G. L. Mandell, R. G. Douglas, and J. E. Bennet (ed.). Practice and principles of infectious diseases. Churchill Livingstone, New York.
21. Shutze, M. P., E. Deriaud, G. Przewlocki, and C. Leclerc. 1989. Carrier-induced epitopic suppression is initiated through clonal dominance. J. Immunol. 1422635-2640.
22. Shutze, M. P., C. Leclerc, M. Jolivet, F. Audibert, and L. Chedid. 1985. Carrier-induced epitope suppression, a major issue for synthetic vaccines. J. Immunol. 1352319-2322.
23. Smith, C. J., J. C. Allen, M. N. Embi, O. Othman, N. Ratzak, and G. Ismail. 1987. Human melioidosis an emerging medical problem. MIRCEN J. 3343-366.
24. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications. Proc. Natl. Acad. Sci. USA 744350-4354.
25. Westphal, O., and K. Jann. 1965. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 2583-91.
26. Woods, D. E., A. L. Jones, and P. J. Hill. 1993. Interaction of insulin with Pseudomonas pseudomallei. Infect. Immun. 614045-4050.
27. Yabuuchi, E., V. Kosako, H. Oyaizu, I. Yano, H. Hota, Y. Hashimoto, T. Ezaki, and M. Arakawa. 1992. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol. Immunol. 361251-1275.